What is Bactolac Pharmaceutical, Inc.?
Founded in 1995 and based in Hauppauge, New York, Bactolac Pharmaceutical, Inc. operates as a comprehensive manufacturer of vitamins and supplements. The company offers a full suite of services, including product manufacturing, rigorous product testing, specialized packaging, and precise label application. Its integrated approach allows it to serve a diverse clientele seeking reliable and high-quality supplement production. The recent major enterprise-level funding and strategic investment signal confidence in Bactolac's operational capabilities and market potential within the health and wellness sector.
How much funding has Bactolac Pharmaceutical, Inc. raised?
Bactolac Pharmaceutical, Inc. has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Bactolac Pharmaceutical, Inc.
PPP
Public-Private Partnership
What's next for Bactolac Pharmaceutical, Inc.?
The recent major strategic investment positions Bactolac Pharmaceutical, Inc. for accelerated growth and enhanced market penetration. This capital infusion is expected to fuel advancements in product development, manufacturing capacity, and potentially expand its service offerings. The company's focus on quality control and comprehensive manufacturing solutions, combined with this strategic backing, suggests a forward-looking strategy aimed at solidifying its leadership in the vitamin and supplement industry. Future developments will likely involve scaling operations and exploring new market opportunities.
See full Bactolac Pharmaceutical, Inc. company page
